These data suggest that the inhibition of breast cancer cell growth caused by BenSer treatment is mediated in part by direct inhibition of multiple amino acid transporters, and not just by inhibition of LAT1 and ASCT2. The gene discussed is LAT; the disease is breast carcinoma.